Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

P3 Health Partners (PIII) EBIT Margin: 2019-2024

Historic EBIT Margin for P3 Health Partners (PIII) over the last 6 years, with FY2024 value amounting to 21.37%.

  • P3 Health Partners' EBIT Margin rose 167400.0% to 12.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.64%, marking a year-over-year decrease of 9600.0%. This contributed to the annual value of 21.37% for FY2024, which is 81100.0% down from last year.
  • P3 Health Partners' EBIT Margin amounted to 21.37% in FY2024, which was down 81100.0% from 13.26% recorded in FY2023.
  • P3 Health Partners' 5-year EBIT Margin high stood at 5.82% for FY2020, and its period low was 148.73% during FY2022.
  • In the last 5 years, P3 Health Partners' EBIT Margin had a median value of 21.37% in 2024 and averaged 42.3%.
  • As far as peak fluctuations go, P3 Health Partners' EBIT Margin surged by 1354700bps in 2023, and later tumbled by -81100bps in 2024.
  • P3 Health Partners' EBIT Margin (Annual) stood at 5.82% in 2020, then plummeted by -283bps to 22.31% in 2021, then crashed by -567bps to 148.73% in 2022, then skyrocketed by 91bps to 13.26% in 2023, then crashed by -61bps to 21.37% in 2024.
  • Its EBIT Margin was 21.37% in FY2024, compared to 13.26% in FY2023 and 148.73% in FY2022.